Loading
Latest filing published 05 Aug 2026 for 명문제약.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 권용진 in 명문제약, where the filings describe the role as senior executive. We count 2 filings; the first trade dates from 28 April 2026 and the latest from 5 August 2026.
The open-market record is one-sided, with 2 purchases and not one sale. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 5 August 2026, reports an open-market purchase in 명문제약. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.